SMO10 SMO10 SMO10 SMO10 Fast delivery SMO10 White powder 99% High Quality semaglutide weight loss
TDS 1 Inquiries
60177-36-8
Pharmaceutical Grade
99%
HongKong
customizable
10 bottles per box
2026-12-31
GHK-CU,RETATRUTIDE
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
Sorbitan, monooctanoate
Other Name:[(1R)-1-[(3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octanoate;Sorbitan, monooctanoate;Einecs 262-098-3
CAS No.:60177-36-8
Molecular Formula:C14H26O6
InChIKeys:PMRQMYKBMKCWSE-KIPVYSRNSA-N
Molecular Weight:290.35264
Exact Mass:290.17293854
EC Number:262-098-3
TSCA:TSCA listed
Categories:
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
GHK-CU,RETATRUTIDE
-
Location:
Guangzhou Changkai Trading Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
Spain
SORBITAN CAPRYLATE
50 KG Apr 29, 2024 Post an enquiry for this product